Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
TrickyTrees
You’re right,I seem to have lost a zero somewhere.
I wonder where I put it?
It is reported as a definite buy.
Someone’s being nice to their self this Christmas
Meoryou - Senior Independent Director has purchased 160,000 Haleon Eqiuty.
He can afford it, unless their is an allocation ?
Just bought 16,000 shares.
That must be at least a slight positive.
See RNS
Surely the journalistic press ramped up this story to force Unilever to bid.
Otherwise Jope would still be leading Unilever.
I'm not so sure that Jope wasn't quietly booted, but allowed to step down to save face, when really he should have been paraded through the streets naked for investors to throw rotten food at.
That said, the real villain of the whole sorry episode was the GUTLESS OAF of a FD - Graeme Pitkethly who's job it was to reign in moronic decisions made by those with little financial knowledge. A spineless yesman promoted way above his very questionable abilities. Fortunately he's going very soon too - but also sadly allowed to leave on his own terms.
Had Unilever lost its marbles when it offered 50 billions pounds for a company with £20B long term liabilities and was GSK so foolish to turn it down? Haleon has to rise 70% to match that offer. Good luck to all the investors. Jope should have been given the boot to come up with that offer.
On the other hand Unilever is regretting turning down a takeover offer for £40 pounds per share when after 5-6 years it is struggling to stay above £40 per share. Crazy times.
Questor article in Daily Telegraph has updated to say Haleon is solid prospect for rising SP
I listened to the Webcast following the statement. Oh gosh it was boring, listening to Tobias Hestler (CFO) drone on about Sensodyne, Panadol or Centrum sales in different global markets, some where they kept pace with inflationary cost and others where they didn't. All to say in the end that they were still on target to achieve their forecast for FY 2023 the Company continues to expect:-
Organic revenue growth to be 7-8%
Adjusted operating profit growth to be 9-11% constant currency
Net interest expense of c.£350m
Adjusted effective tax rate of 23-24%
Not surprised the shares fell on the results. If their old parent company (GSK) fell when it announced a profit upgrade yesterday why should HLN rise today? (Watch out for a weakening US Dollar; this will hit their targets on the downside.)
Formal announcement
https://www.londonstockexchange.com/news-article/GSK/gsk-completes-sale-of-shares-in-haleon-plc/16155443
"GSK to sell £900m stake in British consumer goods giant Haleon
GSK is poised to sell its £900m stake in British consumer goods giant Haleon.
The pharmaceutical giant announced on Thursday plans to offload 270m shares in Haleon, equivalent to approximately 2.9pc of the company’s listed stock. "
From today's Telegraph, as I suggested a few months ago, 335 or thereabouts is an upper boundary for HLN as the committed sellers ie GSK and Pfizer are keen to offload their major interest here .
Holders should recognise this and consider their positions accordingly, remembering that GSK and Pfizer between them hold about half of Haleon stock.
The Chairman and CEO are very experienced.
Haleon SP to rise as certain non-essential portfolio brands are sold & Net debt is reduced.
'I think I would say don’t underestimate the transformation from being part of a bigger entity to suddenly being a stand-alone firm'
I think I would say don’t underestimate the transformation from being part of a bigger entity to suddenly being a stand-alone firm
Ex - Divi day today.
Future is bright for Haleon.
The chairman & CEO work well together.
Good summary
I do wonder if someone like Ulvr or similar might at some time come in and take a strategic holding ( perhaps 10%) just to be at the table in future discussions on brands for sale or if a bid came in.
Not really expecting anything soon ,with all the debt they have, but with the big share overhang someone might be able to get a good deal.
Failing that it’s all about paying down the debt, and waiting on developments on the share overhang.
I’m hoping when that finally happens we can maybe see some of the value the Ulvr bid saw be realised.
I don't hold here so if you choose to see my input as irrelevant , feel free. Nevertheless, as a former holder of both GSK and ULVR I watch this space and I thought I could add some helpful comment on prospects here. The latest figures are broadly positive, revenues up ~10% BUT most of that is price increases and there is less scope for further increases as inflation starts to level out ,margins were in fact down 22%and free cash was ~£370 million .
The problems with which Haleon was saddled at birth still loom large, a huge slew of debt which at the present level of income will be with the company for several years, and two major investors in GSK and Pfizer committed to selling their holdings which are about 50% of the equity . GSK's sale in May at 335p effectively puts a cap on the SP , it is a reasonable assumption that either GSK or Pfizer will unload if/when the SP hits that number again, and exceeding it is highly improbable for the foreseeable future. Additionally I learn that both companies are trying to pressure HLN to indemnify them against any costs arising out of the Zantac litigation . IMV that is an appalling abdication of responsibility by both boards and lowers my already poor opinion of Emma Walmsley.
It seems that HLN are trying to fund debt reduction by selling off some of their brands, yesterday's Times mentions Nicotinell and ChapStick. So in summary, I don't see HLN's SP moving up much and I see little prospect of significant divis for a significant time.
I don't do investment advice , so draw your own conclusions.
All today with factors affecting stock market.
Downgrading on USA by Fitch to AA+ & BOE Borrowing rate increase to 5.25% tomorrow.
Good buying oppo.
When Unilever and Reckitt are in the high teens.
And yet again another company punished for good results by sp dropping.
So just bought some more.
Yesterday analysts were expecting revenue at £5,687m and an adjusted EBITDA of £1,316m. Todays actual results show a revenue of £5,738m and EBITDA of £1,406m. As this is above market expectations, by about 1% and 7% respectively, I would expect this to result in an uprate of the SP.
Good to see on UK TV Channels its products - ensures public are aware of Haleon.
The SP has been heading north.
USA sales for this product should increase, also UK & Middle East.
Hopefully Haleon SP should increase - maybe even 'Erictile' northwards.